Restatement reclassified certain prepaid contracts as warrants, recognized pending share issuances as outstanding, reduced certain expenses, and recorded debt conversion losses.
Restated quarterly results
Preaxia Health Care Payment Systems filed restated quarterly financial results for the three months ended Aug. 31, 2025.
Net loss was USD 745,208, reflecting USD 576,134 in operating expenses, with USD 169,143 loss on settlement of debt.
Cash and cash equivalents totaled USD 130,285 at Aug. 31, 2025, with total assets at USD 130,285.
Working capital deficit was USD 605,757, with shareholders’ deficit of USD 605,757, versus USD 2.34 million at May 31, 2025.
PAXH•
